As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
We received an updated WNV package insert; please note the manufacturer and license number has been ...